Tumor Analysis Platform Predicts Personalized Drug Combos for Non-Hodgkin Lymphoma Patients
Among NHL patients who received off-label therapy with combinations generated by the platform, nearly half achieved partial or complete responses.
Source: precisiononcologynews.com